| Lakan Karlo G Magat, MD | |
|
2300 Pennsylvania Ave, Suite 1a, Wilmington, DE 19806-1392 | |
| (302) 655-0355 | |
| (302) 655-4833 |
| Full Name | Lakan Karlo G Magat |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 2300 Pennsylvania Ave, Wilmington, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033151642 | NPI | - | NPPES |
| 1000035284 | Medicaid | DE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | C1-0007354 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christiana Hospital | Newark, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Family Medical Associates Of Delaware | 3274530217 | 2 |
| United Medical Clinic, Llc | 6406039965 | 10 |
News Archive
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.
But during a Wednesday congressional hearing, Department of Health and Human Services officials made clear that they really have stopped implementing the health law's long-term care insurance program, despite continuing pleas to give it another chance.
Barrett's oesophagus is a metaplastic disorder that develops in about 10% of people with chronic gastro-oesophageal reflux disease. Every year about 0.5%-1% of patients with Barrett's oesophagus develop oesophageal adenocarcinoma.
A breakthrough study led by the University of Sydney's Brain and Mind Centre and Royal Prince Alfred Hospital has revealed unique molecules in the blood of people with Multiple Sclerosis (MS) that could become definitive diagnostic biomarkers of the world's most common neurologic disability in young adults.
› Verified 5 days ago
| Entity Name | Family Medical Associates Of Delaware |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902840226 PECOS PAC ID: 3274530217 Enrollment ID: O20061103000311 |
News Archive
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.
But during a Wednesday congressional hearing, Department of Health and Human Services officials made clear that they really have stopped implementing the health law's long-term care insurance program, despite continuing pleas to give it another chance.
Barrett's oesophagus is a metaplastic disorder that develops in about 10% of people with chronic gastro-oesophageal reflux disease. Every year about 0.5%-1% of patients with Barrett's oesophagus develop oesophageal adenocarcinoma.
A breakthrough study led by the University of Sydney's Brain and Mind Centre and Royal Prince Alfred Hospital has revealed unique molecules in the blood of people with Multiple Sclerosis (MS) that could become definitive diagnostic biomarkers of the world's most common neurologic disability in young adults.
› Verified 5 days ago
| Entity Name | Inpatient Consultants Of Delaware, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073706099 PECOS PAC ID: 1850472390 Enrollment ID: O20080125000125 |
News Archive
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.
But during a Wednesday congressional hearing, Department of Health and Human Services officials made clear that they really have stopped implementing the health law's long-term care insurance program, despite continuing pleas to give it another chance.
Barrett's oesophagus is a metaplastic disorder that develops in about 10% of people with chronic gastro-oesophageal reflux disease. Every year about 0.5%-1% of patients with Barrett's oesophagus develop oesophageal adenocarcinoma.
A breakthrough study led by the University of Sydney's Brain and Mind Centre and Royal Prince Alfred Hospital has revealed unique molecules in the blood of people with Multiple Sclerosis (MS) that could become definitive diagnostic biomarkers of the world's most common neurologic disability in young adults.
› Verified 5 days ago
| Entity Name | Christiana Care Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245474329 PECOS PAC ID: 9739097569 Enrollment ID: O20091027000729 |
News Archive
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.
But during a Wednesday congressional hearing, Department of Health and Human Services officials made clear that they really have stopped implementing the health law's long-term care insurance program, despite continuing pleas to give it another chance.
Barrett's oesophagus is a metaplastic disorder that develops in about 10% of people with chronic gastro-oesophageal reflux disease. Every year about 0.5%-1% of patients with Barrett's oesophagus develop oesophageal adenocarcinoma.
A breakthrough study led by the University of Sydney's Brain and Mind Centre and Royal Prince Alfred Hospital has revealed unique molecules in the blood of people with Multiple Sclerosis (MS) that could become definitive diagnostic biomarkers of the world's most common neurologic disability in young adults.
› Verified 5 days ago
| Entity Name | United Medical Clinic, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396046108 PECOS PAC ID: 6406039965 Enrollment ID: O20110322000499 |
News Archive
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.
But during a Wednesday congressional hearing, Department of Health and Human Services officials made clear that they really have stopped implementing the health law's long-term care insurance program, despite continuing pleas to give it another chance.
Barrett's oesophagus is a metaplastic disorder that develops in about 10% of people with chronic gastro-oesophageal reflux disease. Every year about 0.5%-1% of patients with Barrett's oesophagus develop oesophageal adenocarcinoma.
A breakthrough study led by the University of Sydney's Brain and Mind Centre and Royal Prince Alfred Hospital has revealed unique molecules in the blood of people with Multiple Sclerosis (MS) that could become definitive diagnostic biomarkers of the world's most common neurologic disability in young adults.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lakan Karlo G Magat, MD 2300 Pennsylvania Ave, Suite 1a, Wilmington, DE 19806-1392 Ph: (302) 655-0355 | Lakan Karlo G Magat, MD 2300 Pennsylvania Ave, Suite 1a, Wilmington, DE 19806-1392 Ph: (302) 655-0355 |
News Archive
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.
But during a Wednesday congressional hearing, Department of Health and Human Services officials made clear that they really have stopped implementing the health law's long-term care insurance program, despite continuing pleas to give it another chance.
Barrett's oesophagus is a metaplastic disorder that develops in about 10% of people with chronic gastro-oesophageal reflux disease. Every year about 0.5%-1% of patients with Barrett's oesophagus develop oesophageal adenocarcinoma.
A breakthrough study led by the University of Sydney's Brain and Mind Centre and Royal Prince Alfred Hospital has revealed unique molecules in the blood of people with Multiple Sclerosis (MS) that could become definitive diagnostic biomarkers of the world's most common neurologic disability in young adults.
› Verified 5 days ago
Jennifer Maxwell, FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4550 New Linden Hill Rd, Wilmington, DE 19808 Phone: 302-525-4337 | |
Charlene Browne, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 31/32 A Trolley Square, Wilmington, DE 19806 Phone: 302-777-5473 | |
Dr. Michelle Elaine Papa, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 S Broom St, Wilmington, DE 19805 Phone: 302-656-5416 Fax: 302-656-5435 | |
Heather Bittner-fagan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1401 Foulk Rd, Suite 100b, Wilmington, DE 19803 Phone: 302-477-3300 Fax: 302-477-3168 | |
Patricia F Bankes, CRNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1072 Justison St, Wilmington, DE 19801 Phone: 302-661-7400 Fax: 302-661-7476 | |
Steven E. Diamond, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 900 Foulk Rd, Suite 200, Wilmington, DE 19803 Phone: 302-655-8868 Fax: 302-655-3744 |